-
All
81
-
Harvard Business School
29
-
Harvard College
22
-
Harvard Divinity School
1
-
Harvard Extension School
2
-
Harvard Faculty of Arts and Sciences
1
-
Harvard Graduate School of Arts and Sciences
7
-
Harvard Graduate School of Design
4
-
Harvard Graduate School of Education
3
-
Harvard John A. Paulson School of Engineering and Applied Sciences
9
-
Harvard Kennedy School
16
-
Harvard Law School
8
-
Harvard Medical School
20
-
Harvard School of Dental Medicine
3
-
Harvard T.H. Chan School of Public Health
8
-
Harvard University
1
-
Non-Harvard Affiliate
18
-
Adolescent Health Champions
Using peer-to-peer education to train adolescents in India in critical health topics.
-
Aldatu Biosciences
Advancing infectious disease diagnostics that facilitate society's collective response to global health emergencies.
-
Concerto Biosciences
Discovering microbial ensembles for health via a patented screening platform.
-
Day Zero Diagnostics
Developing technologies to help control healthcare-associated infections (HAIs), where antibiotic resistant organisms can be especially dangerous.
-
Lightmatter
Developing photonic computing products that simultaneously reduce the power consumption and increase the performance of silicon running the most advanced AI and HPC workloads.
-
Mozambique School Lunch Initiative
Providing nutritious school meals to children attending rural primary schools in Mozambique.
-
Oze
Supercharging business across Africa with simple tools, smooth payments, affordable capital, and digital shops.
-
Patient First AI
Designing an AI-powered app to help students submit their health forms effortlessly, providing real-time feedback on compliance status and addressing any issues that may arise.
-
UrSure
UrSure was acquired by OraSure Technologies. The company developed urine and blood tests that measure and improve adherence to medications.
-
Vincere Health
Vincere Health was acquired by RVO Health. The company developed a healthcare technology platform to motivate people to smoke less, walk more, and live healthier lives.
-
X-COR Therapeutics
Creating the first commercially-available extracorporeal CO2 removal device that uses ultra-low-blood flow to treat patients with hypercarbic respiratory failure.
Take On the Challenge
Students: Apply for the PIC by Dec. 05.